Discover 3,049 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,049
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
for
Low Grade Upper Tract Urothelial Carcinoma
Location: Los Angeles CA, Loma Linda CA, Austin TX, Dallas TX,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 18+
Code: NCT07265947
Phase 2, Recruiting
Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
for
Malignant Brain Neoplasm,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07339085
Recruiting
Down Syndrome Obstructive Sleep Apnea
for
Down Syndrome, Obstructive Sleep Apnea
Location: Los Angeles CA, Seattle WA, Cincinnati OH, Ann Arbor MI,
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 5 - 18
Code: NCT06043440
Phase 2, Recruiting
New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss
for
Hearing Loss, Bilateral (Causes Other Than Tumors)
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 60+
Code: NCT06781749
Recruiting
Neurophysiologic Biomarkers in Rett Syndrome
for
Rett Syndrome, RTT, Rett Syndrome, Atypical
Location: Los Angeles CA, Aurora CO, Houston TX, Nashville TN,
Sponsor: Children's Hospital of Philadelphia
Sex: Female
Age: 1 - 18
Code: NCT05932589
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
for
Leukemia, Juvenile Myelomonocytic, JMML, JCML,
Location: Los Angeles CA, San Francisco CA, Phoenix AZ,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Sex: All
Age: 0 - 21
Code: NCT05849662
Phase 1, Phase 2, Recruiting
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Los Angeles CA, Orange CA, Irvine CA, Portland OR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06980038
Phase 2, Recruiting
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Duarte CA, Houston TX, Iowa City IA, Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07109219
Phase 1, Phase 2, Recruiting
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
for
B-All, Acute Lymphoblastic Leukemia
Location: Los Angeles CA, Salt Lake City UT, Seattle WA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 25
Code: NCT05621291
Recruiting
International Rare Histiocytic Disorders Registry (IRHDR)
for
Rare Histiocytic Disorders (RHDs),
Location: Los Angeles CA, Madera CA, Birmingham AL, Pittsburgh PA,
Sponsor: The Hospital for Sick Children
Sex: All
Age: 0+
Code: NCT02285582
Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue